RHYTHM PHARMACEUTICALS, INC. Increase (Decrease) in Derivative Liabilities
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Increase (Decrease) in Derivative Liabilities of $560.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for the quarter ending 2026-06-30 was $230.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for the quarter ending 2026-03-31 was $330.00K, a 312.50% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was -$130.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was -$360.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for fiscal 2025 was -$910.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for fiscal 2024 was -$1.42M.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for fiscal 2023 was -$190.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in derivative liabilities for fiscal 2022 was -$250.00K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $560.00K 10-Q · filed 2026-08-04 | $430.00K derived: sum of 3 quarters · filed 2026-08-04 | $70.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $330.00K 10-Q · filed 2026-05-05 | $200.00K derived: sum of 2 quarters · filed 2026-05-05 | -$160.00K derived: sum of 3 quarters · filed 2026-05-05 | -$660.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$490.00K derived: sum of 2 quarters · filed 2026-02-26 | -$990.00K derived: sum of 3 quarters · filed 2026-08-04 | -$910.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$860.00K derived: sum of 2 quarters · filed 2026-08-04 | -$780.00K 10-Q · filed 2025-11-04 | -$900.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$420.00K 10-Q · filed 2026-08-04 | -$540.00K derived: sum of 3 quarters · filed 2026-08-04 | -$1.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-05 | -$40.00K derived: sum of 2 quarters · filed 2026-05-05 | -$550.00K derived: sum of 3 quarters · filed 2026-05-05 | -$850.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$630.00K derived: sum of 2 quarters · filed 2026-02-26 | -$930.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.42M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$810.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.30M 10-Q · filed 2025-11-04 | -$1.34M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$790.00K 10-Q · filed 2025-08-05 | -$830.00K derived: sum of 3 quarters · filed 2026-02-26 | -$960.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$490.00K 10-Q · filed 2025-05-07 | -$530.00K derived: sum of 2 quarters · filed 2026-02-26 | -$660.00K derived: sum of 3 quarters · filed 2026-02-26 | -$630.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$170.00K derived: sum of 2 quarters · filed 2026-02-26 | -$140.00K derived: sum of 3 quarters · filed 2026-02-26 | -$190.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$100.00K derived: sum of 2 quarters · filed 2024-11-06 | -$150.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$20.00K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$50.00K 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$250.00K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |